Episode 1: From SF Healthcare Week, Matt interviews Brad Loncar about M&A and China's potential impact on it

For the first episode of the new video podcast, Matt turns the tables on Brad Loncar and interviews him about his experiences and knowledge of investing in China biotech over the years. They discuss the rise of China biotech and how it might or might not be impacting M&A in the sector.